Advertisement
Technical note| Volume 109, 102587, May 2023

Download started.

Ok

Formation of spread-out Bragg peak for helium-ion beam using microdosimetric kinetic model

Published:April 21, 2023DOI:https://doi.org/10.1016/j.ejmp.2023.102587

      Highlights

      • Some biological model is needed to establish radiation therapy with helium-ions.
      • A biological model used for carbon-ion radiotherapy was investigated.
      • A ridge filter was designed and fabricated using the model to form a biologically uniform spread-out Bragg peak.
      • Biological experiments were performed in the spread-out Bragg peak.
      • It was found that the model could be applicable by some modification.

      Abstract

      Purpose

      To evaluate the applicability of microdosimetric kinetic model (MKM) to helium-ion therapy by forming a spread-out Bragg peak (SOBP) of a helium-ion beam using the MKM developed for carbon-ion radiotherapy and confirming the predictions in biological experiments.

      Methods

      Using a ridge filter, a 90-mm wide SOBP for a 210 MeV/u helium-ion beam was created in a broad beam delivery system. The ridge filter was designed such that a uniform biological response was achieved with a cell survival rate of 7% over the SOBP region. Biological experiments were then performed using the SOBP beam in a human salivary gland (HSG) cell line to measure the cell survival rates.

      Results

      The biological responses were uniform in the SOBP region, as expected by the MKM; however, the mean of the measured cell survival rates was (11.2 ± 0.6) % in the SOBP region, which was 60% higher than the designed rate. When investigating the biological parameters of the HSG cell line used in the experiments, we found that they were altered slightly from the MKM parameters used for carbon-ion radiotherapy. The new β parameter reproduced the measured survival rates within 6.5% in the SOBP region.

      Conclusion

      We produced biologically uniform SOBP using MKM for carbon-ion radiotherapy. The measured survival rates in the SOBP region were higher than expected, and the survival rates were reproduced by modifying the MKM parameter. This study was limited to one SOBP, and further investigations are required to prove that MKM is generally applicable to helium-ion radiotherapy.

      Keywords

      1. Introduction

      Between 1975 and 1992, more than 2,200 patients were treated with helium ions at Lawrence Berkeley Laboratory [
      • Chu W.T.
      • Ludewigt B.A.
      • Renner T.R.
      Instrumentation for treatment of cancer using proton and light ion beams.
      ]. Favorable results were reported, particularly for the head and neck region treatments [
      • Mishra K.K.
      • Quivey J.M.
      • Daftari I.K.
      • Weinberg V.
      • Cole T.B.
      • Patel K.
      • et al.
      Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
      ,
      • Char D.H.
      • Kroll S.M.
      • Castro J.
      Ten-year follow-up of helium ion therapy for uveal melanoma.
      ,
      • Castro J.R.
      • Char D.H.
      • Petti P.L.
      • Daftari I.K.
      • Quivey J.M.
      • Singh R.P.
      • et al.
      15 years experience with helium ion radiotherapy for uveal melanoma.
      ,
      • Saunders W.
      • Castro J.R.
      • Chen G.T.
      • Collier J.M.
      • Zink S.R.
      • Pitluck S.
      • et al.
      Helium-ion radiation therapy at the Lawrence Berkeley Laboratory: recent results of a Northern California Oncology Group Clinical Trial.
      ]. However, treatments using helium ions have not been performed since 1992. A promising dosimetric comparison of protons and helium ions in pediatric patients has also been reported [
      • Knäusl B.
      • Fuchs H.
      • Dieckmann K.
      • Georg D.
      Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
      ]. Heidelberg Ion-Beam Therapy Center (HIT) launched the first European clinical program using therapeutic helium-ion beams and the clinical application of raster-scanning helium-ion therapy [
      • Mein S.
      • Dokic I.
      • Klein C.
      • Tessonnier T.
      • Böhlen T.T.
      • Magro G.
      • et al.
      Biophysical modeling and experimental validation of relative biological effectiveness (RBE) for 4He ion beam therapy.
      ] and treated its first patient in 2021 [

      Press Release: Heidelberg Ion Beam Therapy Center treats first patient using helium ion therapy with RayStation. https://www.raysearchlabs.com/media/press-releases/2021/heidelberg-ion-beam-therapy-center-treats-first-patient-using-helium-ion-therapy-with-raystation/, accessed February 15, 2023.

      ].
      The linear energy transfer (LET) of helium ions is approximately 10 keV/μm in the plateau region, similar to that of protons, whereas the LET in the last few millimeters of the Bragg peak is above 20 keV/μm [
      • Kempe J.
      • Gudowska I.
      • Brahme A.
      Depth absorbed dose and LET distributions of therapeutic 1H, 4He, 7Li, and 12C beams.
      ]. Therefore, the relative biological effectiveness (RBE) of a helium-ion beam changes with depth, particularly near the Bragg peak. Thus, variations in the RBE should be considered for the delivery of biologically uniform doses to patients.
      Intensity-modulated particle therapy (IMPT) has been developed with several clinical advantages [
      • Lomax A.J.
      • Boehringer T.
      • Coray A.
      • Egger E.
      • Goitein G.
      • Grossmann M.
      • et al.
      Intensity modulated proton therapy: a clinical example.
      ]. IMPT reduces the doses to organs at risk by optimizing multiple radiation fields. A biological model should consider the RBE during field optimization for particles heavier than protons. In carbon-ion radiotherapy, two methods have been proposed for RBE in a treatment planning system: the local effect model developed at Gesellschaft fur Schwerionenforschung GmbH (GSI) [
      • Krämer M.
      • Scholz M.
      Rapid calculation of biological effects in ion radiotherapy.
      ,
      • Krämer M.
      • Scholz M.
      Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose.
      ] and the microdosimetric kinetic model (MKM) developed at the National Institute of Radiological Sciences [
      • Inaniwa T.
      • Furukawa T.
      • Kase Y.
      • Matsufuji N.
      • Toshito T.
      • Matsumoto Y.
      • et al.
      Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model.
      ,
      • Kase Y.
      • Kanai T.
      • Matsufuji N.
      • Furusawa Y.
      • Elsässer T.
      • Scholz M.
      Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation.
      ]. Another biological model, called BIANCA, was recently proposed [
      • Carante M.P.
      • Aimè C.
      • Cajiao J.J.T.
      • Ballarini F.
      BIANCA, a biophysical model of cell survival and chromosome damage by protons, C-ions and He-ions at energies and doses used in hadrontherapy.
      ] and has shown promising results for the application of helium-ion beams [

      Carante MP, Embriaco A, Aricò G, Ferrari A, Mairani A, Mein S, et al. Biological effectiveness of He-3 and He-4 ion beams for cancer hadrontherapy: a study based on the BIANCA biophysical model. Phys Med Biol. 202; 66: 195009.

      ]. The MKM has already been applied to treatments using helium-ion beams at HIT, although the treatment has not yet been systematically practiced. The MKM is also considered for use in calculating of the RBE of proton beams [
      • Bertolet A.
      • Cortés-Giraldo M.A.
      • Carabe-Fernandez A.
      Implementation of the microdosimetric kinetic model using analytical microdosimetry in a treatment planning system for proton therapy.
      ].
      This study aims to investigate whether the MKM can be applied to the calculation of biological responses in a helium-ion beam. The applicability was verified by forming a biologically uniform spread-out Bragg peak (SOBP) using the MKM and measuring biological responses through experiments with a human salivary gland (HSG) cell line. The SOBP was formed using a range modulator in a helium-ion beam spread laterally by a wobbling system.

      2. Materials and methods

      2.1 MKM

      The MKM is briefly described below. The survival rate of a cell line S, can be expressed as S=exp-Ln, where Ln is the average number of lethal lesions in the cell nucleus. Based on Kase et al. [
      • Kase Y.
      • Kanai T.
      • Matsufuji N.
      • Furusawa Y.
      • Elsässer T.
      • Scholz M.
      Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation.
      ], Ln can be calculated asfollows:
      Ln=α0+βz1DD+βD2,
      (1)


      where α0 and β are parameters in the linear–quadratic (LQ) model in the limit LET = 0 and D is the absorbed dose. The saturation-corrected dose-mean specific energy in a single event, z1D, is given as [
      • Inaniwa T.
      • Furukawa T.
      • Kase Y.
      • Matsufuji N.
      • Toshito T.
      • Matsumoto Y.
      • et al.
      Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model.
      ]:
      z1D=0zsatzf1zdz0zf1zdz,
      (2)


      where f1z is the probability density of z deposited by a single energy-deposition event of a domain (the subnuclear volume defined in the MKM), and zsat is the saturation-corrected specific energy, expressed as
      zsat=z02z1-exp-z2z02.
      (3)


      z0 is the saturation coefficient, expressed as
      z0=(Rn/rd)2β[1+Rn/rd2],
      (4)


      where Rn and rd are the radii of the cell nucleus and the domain, respectively.

      2.2 Formation of an SOBP

      In a laterally broad helium-ion beam, an SOBP is formed by modulating the energy using a range modulator. The depth–dose distribution of the SOBP was calculated by superimposing pristine Bragg curves. The physical dose of an SOBP at a depth of x is expressed as DSOBPx=kwkDk(x), where wk is the weight of the kth Bragg curve and Dk(x) is the depth–dose curve of the kth pristine Bragg curve for which a beam passes through a certain thickness of the range modulator, tk. Dk(x) is written as
      Dkx=fxI(x,ctk)exp-μtk,
      (5)


      where I(x,ctk) is the planar integrated depth–dose curve in water (IDD) of a helium-ion beam and c is the factor that converts the physical thickness to water-equivalent thickness, which is obtained from the ratio of the material stopping power to that of water. The IDDs for various thicknesses of the range modulator were obtained from I(x,0), which was calculated using a Monte Carlo simulation toolkit, PTSim [
      • Aso T.
      • Kimura A.
      • Kameoka S.
      • Murakami K.
      • Sasaki T.
      • Yamashita T.
      GEANT4 based simulation framework for particle therapy system.
      ]. PTSim was developed for particle therapy based on Geant4 (version 10.6) [
      • Agostinelli S.
      • Allison J.
      • Amako K.
      • Apostolakis J.
      • Araujo H.
      • Arce P.
      • et al.
      Geant4 - a simulation toolkit.
      ]. The details of the derivation of I(x,ctk), are described in the Appendix. Here, f(x) is the fan-beam correction to consider the effect that the beam intensity is inversely proportional to the square of the distance, and it is given by:
      fx=LwxLwy(Lwx-Ls+x)(Lwy-Ls+x),
      (6)


      where Lwx and Lwy are the distances from the wobbling x-magnet and y-magnet to the isocenter, respectively. Ls is the distance from the surface of the water phantom used for the dose profile measurements to the isocenter. This correction was necessary when the water phantom was placed at a fixed position during measurement. The last term of Eq. (5) represents the reduction of helium ions owing to inelastic nuclear interactions. The range modulator used in this study is made of aluminum, and μ is the attenuation coefficient of aluminum, which is calculated as 3.93 × 10-3 mm using the inelastic cross sections of helium ions to aluminum. The cross-section of 652 mb at an energy of 210 MeV/u was obtained from Tripathi99 parameterization [

      Total nuclear reaction cross-section database 2021. https://www.gsi.de/work/forschung/biophysik/fragmentation Accessed December 11, 2021.

      ]. Tripathi99 is one of the best parameterizations that reproduces past experiments for measuring the cross-section of aluminum. The attenuation coefficient was treated as a constant in this study because the variation of the cross-section by Tripathi99 was less than 0.3% between 150 and 210 MeV/u of energy.
      The saturation-corrected specific energy (referred to as the specific energy below) was also obtained using PTSim. The specific energy of a particle i with kinetic energy and energy deposition, (z1D)i, was calculated using Eq. (2). The specific energy was averaged over all particles with doses at depth x, and the dose-mean specific energy, Z(x), was obtained by
      Z(x)=idi(z1D)iidi,
      (7)


      where di is the dose of particle i at a depth of x. The dose-mean specific energy of the SOBP at depth x, ZSOBP(x), is calculated as follows:
      ZSOBP(x)=kwkDk(x)Z(x,ctk)kwkDk(x).
      (8)


      The kth dose-mean specific energy, Z(x,ctk), was obtained by inferring from Z(x,0) (see the Appendix). The survival rate of the SOBP was calculated using Eq. (1), where α(x) and βx at depth x are given by:
      αx=α0+βZSOBP(x)βx=β.
      (9)


      The MKM parameters used in the SOBP formation in this study are summarized in Table 1. Ln in Eq. (1) can be written as Ln=αxD+βxD2 using Eq. (9). The dose of the SOBP at a cell survival rate of S at a depth of x, DHe(x,S), is obtained by solving S=exp-Ln for the dose as
      DHex,S=-αx+α2x-4βxln(S)2β(x).
      (10)


      The RBE is then calculated by Dγ/DHe, where Dγ is the dose of a reference radiation, which is usually a photon, at a cell survival rate of S. The RBE-weighted dose at a depth of x is then obtained by
      BSOBPx=DγDHe(x,S)kwkDk(x).
      (11)


      Table 1MKM parameters used for the SOBP formation. The parameters were obtained from the report of Inaniwa et al.
      • Inaniwa T.
      • Furukawa T.
      • Kase Y.
      • Matsufuji N.
      • Toshito T.
      • Matsumoto Y.
      • et al.
      Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model.
      .
      SymbolQuantityValue
      α0[Gy−1]Linear parameter of the LQ model in the MKM0.172
      β[Gy−2]Quadratic parameter of the LQ model in the MKM0.0615
      rd[μm]Domain radius0.32
      Rn[μm]Nucleus radius3.9
      The number of Bragg curves used to form the SOBP was manually determined to obtain a smooth SOBP curve. The range modulator was designed by optimizing the weights in Eq. (11) such that the RBE-weighted doses in the SOBP region become uniform.

      2.3 Experimental apparatus and procedure

      A series of experiments were performed in the Research and Development (RD) room equipped with a horizontal beam line at the Hyogo Ion Beam Medical Center (HIBMC). The accelerator complex of HIBMC was composed of two electron cyclotron resonance (ECR) ion sources, a linear-accelerator system composed of radiofrequency quadrupole linac (RFQ) and drift-tube linac (DTL), a 30 m-diameter synchrotron, and a high-energy beam transport (HEBT) system. This complex can produce proton, helium-ion, and carbon-ion beams. The beams were transported through the HEBT system to the treatment and experimental rooms. A schematic of the beam delivery system in the RD room is shown in Fig. 1. A 210 MeV/u helium-ion beam was spread laterally using wobbling magnets and a scatterer composed of tantalum. The wobbling radius and scatterer thickness were determined to form a laterally uniform field at the isocenter. The uniformity was within ±3% for a diameter of 160 mm. A 90 mm SOBP was formed using a ridge filter made of aluminum. The ridge filter consisted of 50 bars lined up at 5 mm intervals. The length of each bar was 25 cm and it had a ridge shape, as shown in Fig. 2. The ridge filter was manufactured with a numerically controlled machine by Mitsubishi Electric Corporation (Tokyo, Japan). A dose monitor was placed upstream of the ridge filter to control the delivered dose.
      Figure thumbnail gr1
      Fig. 1Schematic of the beam delivery devices in the Research and Development room at HIBMC.
      Figure thumbnail gr2
      Fig. 2Cross-sectional view of the ridge-bar designed for 90 mm SOBP.
      The lateral and depth–dose profiles were measured using a water phantom MP3-P (PTW Freiburg, Germany). The depth–dose profiles were measured using a parallel-plate ionization chamber ROOS (34001, PTW Freiburg, Germany), while the lateral profiles were measured using a pinpoint ionization chamber (31016, PTW Freiburg, Germany). The absolute absorbed dose was measured in the middle of the SOBP at the isocenter using a parallel-plate ionization chamber Advanced Markus (34045, PTW Freiburg, Germany). The chamber was calibrated using a standard Japanese dosimetry protocol [
      • Fujisaki T.
      • Hiraoka T.
      • Osawa A.
      • Nakajima M.
      • Kuwabara A.
      • Yokoyama K.
      • et al.
      Absorbed dose measurement of photon beam with Farmer-type ionization chambers in Japanese dosimetry protocols.
      ]. The stopping power ratio of water to air (1.130) for helium ions was obtained from IAEA TRS398 [

      IAEA, Technical Report Series No. 398. Absorbed Dose Determination in External Beam Radiotherapy. Vienna: 2000.

      ].
      Biological experiments were performed using HSG cancer cells purchased from the National Institute of Biomedical Innovation [

      National Institute of Biomedical Innovation, Health and Nutrition 2021. https://www.nibiohn.go.jp/en/ Accessed November 30, 2021.

      ]. A colony formation assay was used to measure the cell survival rates over the beam range and fragmentation tail. Cells were incubated in Eagle’s minimum essential medium (Sigma-Aldrich Co., St. Louis, MO) supplemented with 5% fetal bovine serum under standard conditions (at 37.8 ℃, in a humid atmosphere of 5% CO2 in the air). A 25 cm2 plastic flask (Nalge Nunc International, Rochester, NY) on which cells in logarithmic growth were seeded was placed at the isocenter to be irradiated by the SOBP beam. A polyethylene (PE) block with a cross-sectional area of 200 × 200 mm2 was placed in front of the flask to degrade the SOBP beam energy. Ten flasks were irradiated with the SOBP beam by changing the water-equivalent thickness of the block to 77, 117, 157, 177, 197, 217, 237, 257, 277, and 317 mm. The physical thickness of the PE block was calculated using the stopping-power table of ICRU49 [

      ICRU Report 49. Stopping Power and Ranges for Protons and Alpha Particles, Bethesda, Maryland: 1993.

      ] such that the water-equivalent thickness of the PE block becomes the thickness used in the experiment. The density of PE was assumed as 0.94 g/cm3, but it can vary from 0.94 to 0.97 g/cm3. The uncertainty of the stopping power can be up to 3%. The cells in each flask were trypsinized immediately after irradiation and plated on five plastic dishes (diameter: 60 mm) at the appropriate densities for clonogenic assays. Fixation with 10% formalin solution and staining with 1% methylene blue solution of colonies was performed after 14 days of incubation. Colonies consisting of more than 50 cells were considered viable. This experiment was independently performed three times on three different days.

      3. Results

      Fig. 3 shows the measured SOBP depth–dose curve in water with the designed curve. The designed RBE-weighted depth–dose curve is also shown. These curves were normalized in the middle of the SOBP. The dose at the middle of the SOBP was estimated to be 4.59 Gy at a cell survival rate of 7% using Eq. (10). The calculated depth–dose curve reproduced the measured dose curve within a root mean square of 5% over the measured depth.
      Figure thumbnail gr3
      Fig. 3Depth–dose curves of the SOBP in water for the designed physical doses (solid line), designed RBE-weighted doses (dashed line) and measured physical doses (closed circles). The doses are normalized at the middle of the SOBP to 1.
      The cell survival rates were measured at 10 depth points thrice, as mentioned in Section 2.3. Fig. 4 shows the results along with the expected cell survival rates as a function of depth. The cell survival rate at each point was the mean of the number of colonies on the five plates, and the uncertainty of each point was estimated using the standard deviation. The mean cell survival rate over the SOBP region was (11.2 ± 0.6) %, which was higher than the expected rate of 7%. The root mean square deviation from expectation was more than 60% [=(11.2–7.0)/7.0 × 100].
      Figure thumbnail gr4
      Fig. 4Measured survival rates at 10 depth points, represented by the open symbols. Each symbol, circle, triangle, and square, represents three experiments performed independently. The red solid line depicts the cell survival rate curve calculated by the MKM using the parameters in , while the red dotted line depicts the cell survival rate curve calculated using β = 0.0457 Gy−2 (described in ). The green dashed-dotted line was calculated using the parameters by Kase et al., and the blue dashed line using the parameters by Lee et al. (see also ). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

      4. Discussion

      The 90 mm SOBP of the 210 MeV/u helium-ion beam was created using the MKM and ridge filter in the broad beam spread laterally by the wobbling system. Biological responses in the SOBP beam were measured using the HSG cell line using a colony formation assay.
      As expected, biological responses in the SOBP region were uniform. However, the cell survival rate was 60% higher than that expected. One possible reason for this discrepancy is the alteration in the HSG cell line used in this study. Cell sensitivity has been known to vary over time; for example, the passage number affects a cell line’s characteristics. To investigate the alteration of the HSG cell line, the cell survival dose curves were measured at a depth of 25 mm in the plateau region of the Bragg curve of the 210 MeV/u monoenergetic helium-ion beam. The results, along with the MKM estimation, are shown in Fig. 5. The dose-mean specific energy at a depth of 25 mm was approximately 0.5 Gy. The measurements were not reproduced by the MKM using the parameters listed in Table 1. Although Inaniwa et al. [
      • Inaniwa T.
      • Furukawa T.
      • Kase Y.
      • Matsufuji N.
      • Toshito T.
      • Matsumoto Y.
      • et al.
      Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model.
      ] adjusted parameter α0 to reproduce their biological experiments, we could not reproduce the experimental results by modifying the parameter α0. Meanwhile, the MKM estimation using β = 0.0457 Gy−2 was consistent with the experimental results, as shown by the dashed line in Fig. 5. The adjustment was made by minimizing the variance between the measurements and the survival curve by fixing Rn and Rd. The depth-cell survival curve of the SOBP was then recalculated using β = 0.0457 Gy−2. The results are shown as dashed lines in Fig. 4. The cell survival rates over the SOBP region, recalculated using β = 0.0457 Gy−2, were consistent with the measured values. The root mean square of the deviations between the measurement and expectation, with β = 0.0457 Gy−2, was within 6.5%.
      Figure thumbnail gr5
      Fig. 5Cell survival rates of the HSG cell line as a function of the dose of the 210 MeV/u monoenergetic beam at a depth of 25 mm in the plastic block phantom. The open symbols represent the measured data, the solid line represents the cell survival rates calculated by the MKM using β = 0.0615 Gy−2, and the dashed line represents those calculated using β = 0.0457 Gy−2.
      Other MKM parameter sets were presented by Kase et al. [
      • Kase Y.
      • Kanai T.
      • Matsumoto Y.
      • Furusawa Y.
      • Okamoto H.
      • Asaba T.
      • et al.
      Microdosimetric measurements and estimation of human cell survival for heavy-ion beams.
      ] and Lee et al. [

      Lee SH, Mizushima K, Yonai S, Matsumoto S, Mizuno H, Nakaji T, et al. T. Predicting the Biological Effects of Human Salivary Gland Tumour Cells for Scanned 4He-, 12C-, 16O-, and 20Ne-Ion Beams Using an SOI Microdosimeter. Appl Sci 2022; 12(12), 6148.

      ]. These parameters, summarized in Table 2, were applied in this study, and the results are shown in Fig. 4. The survival rates obtained using Lee’s parameter set were higher than those measured. The survival rates obtained by Kase reproduced the measurements well in the plateau region, whereas those in the SOBP region were higher than the measurements. None of these could reproduce the measured survival rates in the SOBP region.
      Table 2MKM parameters presented by Kase et al.
      • Kase Y.
      • Kanai T.
      • Matsumoto Y.
      • Furusawa Y.
      • Okamoto H.
      • Asaba T.
      • et al.
      Microdosimetric measurements and estimation of human cell survival for heavy-ion beams.
      and Lee et al.

      Lee SH, Mizushima K, Yonai S, Matsumoto S, Mizuno H, Nakaji T, et al. T. Predicting the Biological Effects of Human Salivary Gland Tumour Cells for Scanned 4He-, 12C-, 16O-, and 20Ne-Ion Beams Using an SOI Microdosimeter. Appl Sci 2022; 12(12), 6148.

      .
      SymbolLee et alKase et al
      α0[Gy−1]0.070.13
      β[Gy−2]0.04750.05
      rd[μm]0.430.42
      Rn[μm]6.64.1
      A slight difference in the depth–dose curve of the SOBP between the calculation and the measurement is shown in Fig. 3. One possible reason for this is the difference in the pristine Bragg curve of the 210 MeV/u beam between the calculation and measurement, as seen in Fig. A1 in Appendix. The peak-plateau ratio of the measurement was not reproduced well by Geant4. Possible reasons for this difference could be the model of the range straggling and/or the cross section of the helium ions for the water implemented in Geant4. The difference in doses between the calculation and measured values may lead differences in the survival rate, as the difference affects the calculation of the dose-mean saturation-corrected specific energy, z1D. Reproducing the physical behaviors of helium ions by the code is therefore very important to calculate accurate RBEs. We should use a Monte Carlo code or a related code which reproduces the physical behaviors to accurately calculate the dose-mean saturation-corrected specific energy curves, z1D, for clinical use.

      5. Conclusion

      A 90-mm wide SOBP of a 210 MeV/u helium-ion beam was created using the MKM, a biological model for particle beams. The SOBP was formed by using a ridge filter in a laterally spread beam. Biologically uniform responses were successfully obtained in the SOBP region as expected; however, the measured cell survival rate at the SOBP was 60% higher than the expected value. With the new β parameter, MKM could reproduce the measured cell survival rates, and the measurements were in agreement with the expectation within 6.5%. The conclusions drawn in this study are limited to one SOBP, and further investigation of the MKM parameters and physical characteristics of helium ions is required to prove that MKM is generally applicable to helium-ion radiotherapy.

      Declaration of Competing Interest

      The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

      Acknowledgements

      We would like to thank Editage (www.editage.com) for English language editing.

      Appendix A. Modeling of Bragg curves and dose-mean z1D curves

      An SOBP curve was formed by superimposing several pristine Bragg curves in different ranges. Therefore, Bragg curves with different ranges were necessary to calculate the depth–dose curve of the SOBP. Additionally, the dose-mean saturation-corrected specific energy, z1D, curves corresponding to the Bragg curves were also necessary to calculate the biological response of the SOBP. In this study, the Bragg curve and dose-mean z1D curve of a helium-ion beam were inferred from those of the beam used for the formation of the SOBP, that is, the 210 MeV/u beam in this study.
      The planer integrated depth–dose curve of the 210 MeV/u beam and the corresponding dose-mean z1D curve were calculated by dividing into the primary and secondary parts using the Monte Carlo simulation toolkit PTSim. In PTSim, a phantom with dimensions of 300 × 300 × 500 mm3 was constructed by stacking 500 tallies with a thickness of 1 mm. Monoenergetic helium ions were impinged at the center of the phantom. The Bragg curve of the 210 MeV/u beam is shown in Fig. A1 with the measurements.
      Figure thumbnail gr6
      Fig. A1Comparison of the depth–dose curves of the 210 MeV/u beam between the measurement (closed circles) and the calculation (solid line). The calculated depth–dose curve was obtained from the IDD with the fan-beam correction of Eq. . The doses are normalized at the shallowest depth of the measurement.
      The primary and secondary parts of the planer integrated depth–dose curve (IDD) with a shorter beam range by ΔR than the 210 MeV/u beam are modeled as follows:
      I1x,ΔR=w1ΔRI01x+ΔR,I2x,ΔR=w2ΔR/R0I02x1-ΔR/R0,
      (A1)


      where I01 and I02 are the primary and secondary parts of the IDD of the 210 MeV/u beam, respectively. R0 is the beam range of the 210 MeV/u beam, which is defined at an 80% dose level. ΔR corresponds to the water-equivalent thickness at a point on the range modulator through which the beam passes. The total IDD was given by I=I1+ I2.
      The primary and secondary parts of the dose-mean z1D curve (Z1D) are modeled in a similar way to the IDD, as follows:
      Z1x,ΔR=w3ΔRZ01x+ΔR,Z2x,ΔR=w4ΔR/R0Z02x1-ΔR/R0,
      (A2)


      where Z01 and Z02 are the primary and secondary parts of the Z1D of the 210 MeV/u beam, respectively. The total Z1D was given by Z=(Z1I1+Z2I2)/(I1+I2).
      The modeling factors w1w4, were determined such that IDDs and Z1Ds with various ranges were reproduced well, where the IDDs and Z1Ds were also obtained by PTSim. The functional forms of w1-w4 are
      w1t=exp2.37×10-3t,w2t=1-0.179t-0.180t2,w3t=1,w4t=1+0.195t+0.324t2.
      (A3)


      The modeling was performed using IDDs and Z1Ds of 160, 170, 180, 190, and 200 MeV/u beams calculated using PTSim. The energy fluctuation for each beam was determined to reproduce the Bragg peak width of the 210 MeV/u beam. The 210 MeV/u beam was degraded by a range modulator and impinged in water, whereas in the PTSim, the beams were directly impinged into the phantom. The energy fluctuation in the range moderator should be considered when calculating IDDs and Z1Ds. The results of the model are presented in Fig. A2. IDDs and Z1Ds were reproduced well for the primary beam, while slight differences for the secondary beam were seen in a slightly shallower region than the beam range, especially for lower energies. However, the contribution of the secondary beam to the total is small, and the inference and the actual agree within 4% for IDDs and 5% for Z1Ds in the shallower region than the beam range.
      Figure thumbnail gr7
      Fig. A2Comparison of IDDs and Z1Ds with different ranges between inferred curves from the 210 MeV/u beam (solid lines) and calculated curves using PTSim (dash lines), where (a) is IDDs for the primary, (b) is IDDs for the secondary, (c) is Z1Ds for the primary, and (d) is Z1Ds for the secondary.

      References

        • Chu W.T.
        • Ludewigt B.A.
        • Renner T.R.
        Instrumentation for treatment of cancer using proton and light ion beams.
        Rev Sci Instrum. 1993; 64: 2055-2122
        • Mishra K.K.
        • Quivey J.M.
        • Daftari I.K.
        • Weinberg V.
        • Cole T.B.
        • Patel K.
        • et al.
        Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
        Int J Radiat Oncol Biol Phys. 2015; 92: 376-383
        • Char D.H.
        • Kroll S.M.
        • Castro J.
        Ten-year follow-up of helium ion therapy for uveal melanoma.
        Am J Ophthalmol. 1998; 125: 81-89
        • Castro J.R.
        • Char D.H.
        • Petti P.L.
        • Daftari I.K.
        • Quivey J.M.
        • Singh R.P.
        • et al.
        15 years experience with helium ion radiotherapy for uveal melanoma.
        Int J Radiat Oncol Biol Phys. 1997; 39: 989-996
        • Saunders W.
        • Castro J.R.
        • Chen G.T.
        • Collier J.M.
        • Zink S.R.
        • Pitluck S.
        • et al.
        Helium-ion radiation therapy at the Lawrence Berkeley Laboratory: recent results of a Northern California Oncology Group Clinical Trial.
        Radiat Res Suppl. 1985; 8: S227-S234
        • Knäusl B.
        • Fuchs H.
        • Dieckmann K.
        • Georg D.
        Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
        Acta Oncol. 2016 Jun; 55: 751-759
        • Mein S.
        • Dokic I.
        • Klein C.
        • Tessonnier T.
        • Böhlen T.T.
        • Magro G.
        • et al.
        Biophysical modeling and experimental validation of relative biological effectiveness (RBE) for 4He ion beam therapy.
        Radiat Oncol. 2019; 14: 123
      1. Press Release: Heidelberg Ion Beam Therapy Center treats first patient using helium ion therapy with RayStation. https://www.raysearchlabs.com/media/press-releases/2021/heidelberg-ion-beam-therapy-center-treats-first-patient-using-helium-ion-therapy-with-raystation/, accessed February 15, 2023.

        • Kempe J.
        • Gudowska I.
        • Brahme A.
        Depth absorbed dose and LET distributions of therapeutic 1H, 4He, 7Li, and 12C beams.
        Med Phys. 2007; 34: 183-192
        • Lomax A.J.
        • Boehringer T.
        • Coray A.
        • Egger E.
        • Goitein G.
        • Grossmann M.
        • et al.
        Intensity modulated proton therapy: a clinical example.
        Med Phys. 2001; 28: 317-324
        • Krämer M.
        • Scholz M.
        Rapid calculation of biological effects in ion radiotherapy.
        Phys Med Biol. 2006; 51: 1959-1970
        • Krämer M.
        • Scholz M.
        Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose.
        Phys Med Biol. 2000; 45: 3319-3330
        • Inaniwa T.
        • Furukawa T.
        • Kase Y.
        • Matsufuji N.
        • Toshito T.
        • Matsumoto Y.
        • et al.
        Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model.
        Phys Med Biol. 2010; 55: 6721-6737
        • Kase Y.
        • Kanai T.
        • Matsufuji N.
        • Furusawa Y.
        • Elsässer T.
        • Scholz M.
        Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation.
        Phys Med Biol. 2008; 53: 37-59
        • Carante M.P.
        • Aimè C.
        • Cajiao J.J.T.
        • Ballarini F.
        BIANCA, a biophysical model of cell survival and chromosome damage by protons, C-ions and He-ions at energies and doses used in hadrontherapy.
        Phys Med Biol. 2018; 63075007
      2. Carante MP, Embriaco A, Aricò G, Ferrari A, Mairani A, Mein S, et al. Biological effectiveness of He-3 and He-4 ion beams for cancer hadrontherapy: a study based on the BIANCA biophysical model. Phys Med Biol. 202; 66: 195009.

        • Bertolet A.
        • Cortés-Giraldo M.A.
        • Carabe-Fernandez A.
        Implementation of the microdosimetric kinetic model using analytical microdosimetry in a treatment planning system for proton therapy.
        Phys Med. 2021; 81: 69-76https://doi.org/10.1016/j.ejmp.2020.11.024
        • Aso T.
        • Kimura A.
        • Kameoka S.
        • Murakami K.
        • Sasaki T.
        • Yamashita T.
        GEANT4 based simulation framework for particle therapy system.
        Nucl Sci Symp IEEE Conf Rec. 2007; 4: 2564-2567
        • Agostinelli S.
        • Allison J.
        • Amako K.
        • Apostolakis J.
        • Araujo H.
        • Arce P.
        • et al.
        Geant4 - a simulation toolkit.
        Nucl Instrum Meth A. 2003; 506: 250-303
      3. Total nuclear reaction cross-section database 2021. https://www.gsi.de/work/forschung/biophysik/fragmentation Accessed December 11, 2021.

        • Fujisaki T.
        • Hiraoka T.
        • Osawa A.
        • Nakajima M.
        • Kuwabara A.
        • Yokoyama K.
        • et al.
        Absorbed dose measurement of photon beam with Farmer-type ionization chambers in Japanese dosimetry protocols.
        Igaku Butsuri. 2004; 24: 13-20
      4. IAEA, Technical Report Series No. 398. Absorbed Dose Determination in External Beam Radiotherapy. Vienna: 2000.

      5. National Institute of Biomedical Innovation, Health and Nutrition 2021. https://www.nibiohn.go.jp/en/ Accessed November 30, 2021.

      6. ICRU Report 49. Stopping Power and Ranges for Protons and Alpha Particles, Bethesda, Maryland: 1993.

        • Kase Y.
        • Kanai T.
        • Matsumoto Y.
        • Furusawa Y.
        • Okamoto H.
        • Asaba T.
        • et al.
        Microdosimetric measurements and estimation of human cell survival for heavy-ion beams.
        Radiat Res. 2006; 166: 629-638
      7. Lee SH, Mizushima K, Yonai S, Matsumoto S, Mizuno H, Nakaji T, et al. T. Predicting the Biological Effects of Human Salivary Gland Tumour Cells for Scanned 4He-, 12C-, 16O-, and 20Ne-Ion Beams Using an SOI Microdosimeter. Appl Sci 2022; 12(12), 6148.